In the News
Yuanbin Chen, MD, JTO Clinical & Research Reports
05/23/2022
Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, is published from CASPIAN on JTO as first author from CHCWM. DR. Chen reports this is the first time that immunotherapy plus chemotherapy works in small cell lung cancer Read more »
Yuanbin Chen, MD, European Lung Cancer Congress
04/18/2022
Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, is featured in a study with the European Lung Cancer Congress, Characteristics of Long-Term Survivors in the CASPIAN study. “There were >3 times as many LTS in the D+EP Read more »
CHCWM’s Tami Groothuis, NP, partners with Livestrong program
11/30/2021
Cancer & Hematology Centers of Western Michigan (CHCWM)’s Tami Groothuis, NP, recently beat cancer and is paying it forward by becoming a Livestrong coach, offering fitness classes for cancer survivors at the YMCA of Greater Grand Rapids. She spoke recently Read more »
START Midwest physician and clinical trial featured on ‘OncLive’
11/23/2021
START Midwest’s Nehal Lakhani, MD, PhD, was recently featured on OncLive after his poster examining SL-172154 (SIRPα-Fc-CD40L) was presented at the 2021 Society for Immunotherapy of Cancer (SITC)’s Annual Meeting. The investigative agent was found to be “well tolerated with Read more »
CHC physician talks with Gilda’s Club Grand Rapids
10/08/2021
Cancer & Hematology Centers of Western Michigan (CHC)’s Brett Brinker, MD, MS, recently spoke with Gilda’s Club Grand Rapids in honor of Blood Cancer Awareness Month. The discussion, which premiered on Facebook Live and highlighted blood cancer diagnosis, treatment and Read more »
Two Yuanbin Chen, MD, studies presented at ESMO 2021 Congress
10/04/2021
Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, co-authored two studies recently presented at the European Society for Medical Oncology (ESMO)’s 2021 Congress. The first study was presented as an Eposter display titled, “1666TiP – Phase II Read more »